← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Omega Fund Iv, L.P. sold $1.4M of Replimune Group, Inc.

Director and 10% owner

Sold$1,378,444
$45.42Price
30,350Shares
−1%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, Jan 26. Filed Thu, Jan 28, 4:27 AM ET, before the open. Not investment advice.